GT Biopharma, Inc. - Common Stock (GTBP)

CUSIP: 36254L308

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock
Shares outstanding
3,148,458
Total 13F shares
198,676
Share change
+98,978
Total reported value
$711,263
Price per share
$3.58
Number of holders
21
Value change
+$381,370
Number of buys
11
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 36254L308?
CUSIP 36254L308 identifies GTBP - GT Biopharma, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GT Biopharma, Inc. - Common Stock (GTBP) as of Q2 2025

As of 30 Jun 2025, GT Biopharma, Inc. - Common Stock (GTBP) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 198,676 shares. The largest 10 holders included BANK OF MONTREAL /CAN/, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, OSAIC HOLDINGS, INC., VANGUARD GROUP INC, WELLS FARGO & COMPANY/MN, BlackRock, Inc., UBS Group AG, MORGAN STANLEY, and Newbridge Financial Services Group, Inc.. This page lists 21 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.